146 related articles for article (PubMed ID: 32469990)
21. Factors affecting uptake and completion of isoniazid preventive therapy among HIV-infected children at a national referral hospital, Kenya: a mixed quantitative and qualitative study.
Ngugi SK; Muiruri P; Odero T; Gachuno O
BMC Infect Dis; 2020 Apr; 20(1):294. PubMed ID: 32664847
[TBL] [Abstract][Full Text] [Related]
22. Early-phase scale-up of isoniazid preventive therapy for people living with HIV in two districts in Malawi (2017).
Nabity SA; Gunde LJ; Surie D; Shiraishi RW; Kirking HL; Maida A; Auld AF; Odo M; Jahn A; Nyirenda RK; Oeltmann JE
PLoS One; 2021; 16(4):e0248115. PubMed ID: 33793577
[TBL] [Abstract][Full Text] [Related]
23. Predictors of adherence to isoniazid preventive therapy in people living with HIV in Ethiopia.
Ayele HT; van Mourik MS; Bonten MJ
Int J Tuberc Lung Dis; 2016 Oct; 20(10):1342-1347. PubMed ID: 27725045
[TBL] [Abstract][Full Text] [Related]
24. Predictors of isoniazid preventive therapy completion among adults newly diagnosed with HIV in rural Malawi.
Little KM; Khundi M; Barnes GL; Ngwira LG; Nkhoma A; Makombe S; Corbett EL; Chaisson RE; Dowdy DW
Int J Tuberc Lung Dis; 2018 Apr; 22(4):371-377. PubMed ID: 29562983
[TBL] [Abstract][Full Text] [Related]
25. Acceptability and adherence to Isoniazid preventive therapy in HIV-infected patients clinically screened for latent tuberculosis in Dar es Salaam, Tanzania.
Shayo GA; Moshiro C; Aboud S; Bakari M; Mugusi FM
BMC Infect Dis; 2015 Aug; 15():368. PubMed ID: 26306511
[TBL] [Abstract][Full Text] [Related]
26. The effect of isoniazid preventive therapy on incidence of tuberculosis among HIV-infected clients under pre-ART care, Jimma, Ethiopia: a retrospective cohort study.
Assebe LF; Reda HL; Wubeneh AD; Lerebo WT; Lambert SM
BMC Public Health; 2015 Apr; 15():346. PubMed ID: 25886730
[TBL] [Abstract][Full Text] [Related]
27. Effectiveness of isoniazid preventative therapy in reducing incidence of active tuberculosis among people living with HIV/AIDS in public health facilities of Addis Ababa, Ethiopia: a historical cohort study.
Semu M; Fenta TG; Medhin G; Assefa D
BMC Infect Dis; 2017 Jan; 17(1):5. PubMed ID: 28049455
[TBL] [Abstract][Full Text] [Related]
28. Barriers to and motivations for the implementation of a treatment programme for latent tuberculosis infection using isoniazid for people living with HIV, in upper northern Thailand.
Moolphate S; Lawpoolsri S; Pungrassami P; Sanguanwongse N; Yamada N; Kaewkungwal J
Glob J Health Sci; 2013 Mar; 5(4):60-70. PubMed ID: 23777722
[TBL] [Abstract][Full Text] [Related]
29. Predictors of suboptimal adherence to isoniazid preventive therapy among adolescents and children living with HIV.
Kay AW; Thivalapill N; Skinner D; Dube GS; Dlamini N; Mzileni B; Fuentes P; Ustero P; Adams LV; Mandalakas AM
PLoS One; 2020; 15(12):e0243713. PubMed ID: 33332462
[TBL] [Abstract][Full Text] [Related]
30. Effect of isoniazid preventive therapy on tuberculosis incidence and associated risk factors among HIV infected adults in Tanzania: a retrospective cohort study.
Sabasaba A; Mwambi H; Somi G; Ramadhani A; Mahande MJ
BMC Infect Dis; 2019 Jan; 19(1):62. PubMed ID: 30654753
[TBL] [Abstract][Full Text] [Related]
31. Factors affecting the acceptability of isoniazid preventive therapy among healthcare providers in selected HIV clinics in Nairobi County, Kenya: a qualitative study.
Wambiya EOA; Atela M; Eboreime E; Ibisomi L
BMJ Open; 2018 Dec; 8(12):e024286. PubMed ID: 30573488
[TBL] [Abstract][Full Text] [Related]
32. Improving coverage and completion rate of isoniazid preventive therapy among eligible HIV patients using quality improvement approaches: a case study of State Hospital, Ijebu Ode, Ogun State, Nigeria.
Ogunsola OO; Ajayi O; Ojo O; Adeyeye O; Akinro Y; Oke O; Adurogbola AA; Olajide O
Pan Afr Med J; 2019; 34():193. PubMed ID: 32180867
[TBL] [Abstract][Full Text] [Related]
33. Health system challenges: An obstacle to the success of isoniazid preventive therapy.
Okoli EI; Roets L
S Afr Med J; 2016 Nov; 106(11):1079-1081. PubMed ID: 27842624
[TBL] [Abstract][Full Text] [Related]
34. Modelling the performance of isoniazid preventive therapy for reducing tuberculosis in HIV endemic settings: the effects of network structure.
Mills HL; Cohen T; Colijn C
J R Soc Interface; 2011 Oct; 8(63):1510-20. PubMed ID: 21508012
[TBL] [Abstract][Full Text] [Related]
35. Isoniazid preventive therapy completion between July-September 2019: A comparison across HIV differentiated service delivery models in Uganda.
Mugenyi L; Namuwenge PM; Ouma S; Bakashaba B; Nanfuka M; Zech J; Agaba C; Mijumbi Ojok A; Kaliba F; Bossa Kato J; Opito R; Miya Y; Katureebe C; Hirsch-Moverman Y
PLoS One; 2024; 19(1):e0296239. PubMed ID: 38166009
[TBL] [Abstract][Full Text] [Related]
36. Tuberculosis outcomes and drug susceptibility in individuals exposed to isoniazid preventive therapy in a high HIV prevalence setting.
van Halsema CL; Fielding KL; Chihota VN; Russell EC; Lewis JJ; Churchyard GJ; Grant AD
AIDS; 2010 Apr; 24(7):1051-5. PubMed ID: 20299958
[TBL] [Abstract][Full Text] [Related]
37. Coverage of isoniazid preventive therapy among people living with HIV; A retrospective cohort study in Tanzania (2012-2016).
Maokola W; Ngowi B; Lawson L; Robert M; Mahande M; Todd J; Msuya S
Int J Infect Dis; 2021 Feb; 103():562-567. PubMed ID: 33276111
[TBL] [Abstract][Full Text] [Related]
38. Isoniazid preventive therapy: Uptake, incidence of tuberculosis and survival among people living with HIV in Bulawayo, Zimbabwe.
Nyathi S; Dlodlo RA; Satyanarayana S; Takarinda KC; Tweya H; Hove S; Matambo R; Mandewo W; Nyathi K; Sibanda E; Harries AD
PLoS One; 2019; 14(10):e0223076. PubMed ID: 31581271
[TBL] [Abstract][Full Text] [Related]
39. Predictors of isoniazid preventive therapy completion among HIV-infected patients receiving differentiated and non-differentiated HIV care in rural Uganda.
Tram KH; Mwangwa F; Chamie G; Atukunda M; Owaraganise A; Ayieko J; Jain V; Clark TD; Kwarisiima D; Petersen ML; Kamya MR; Charlebois ED; Havlir DV; Marquez C;
AIDS Care; 2020 Jan; 32(1):119-127. PubMed ID: 31181961
[TBL] [Abstract][Full Text] [Related]
40. Implementing isoniazid preventive therapy in a tuberculosis treatment-experienced cohort on ART.
Maharaj B; Gengiah TN; Yende-Zuma N; Gengiah S; Naidoo A; Naidoo K
Int J Tuberc Lung Dis; 2017 May; 21(5):537-543. PubMed ID: 28399969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
